TAK - Takeda Pharmaceutical Company Limited

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 51.62B
Enterprise value 78.09B
Trailing P/E 25.04
Forward P/E 11.56
PEG Ratio (5 yr expected) 0.61
Price/sales (ttm)1.75
Price/book (mrq)1.11
Enterprise value/revenue 0.02
Enterprise value/EBITDA 0.06

Trading information

Stock price history

Beta (5Y monthly) 0.68
52-week change 316.64%
S&P500 52-week change 33.90%
52-week high 317.15
52-week low 312.28
50-day moving average 316.53
200-day moving average 315.06

Share statistics

Avg vol (3-month) 32.33M
Avg vol (10-day) 31.82M
Shares outstanding 53.12B
Implied shares outstanding 6N/A
Float 83.07B
% held by insiders 10.00%
% held by institutions 12.22%
Shares short (14 May 2023) 45.74M
Short ratio (14 May 2023) 42.9
Short % of float (14 May 2023) 4N/A
Short % of shares outstanding (14 May 2023) 40.18%
Shares short (prior month 13 Apr 2023) 45.62M

Dividends & splits

Forward annual dividend rate 40.66
Forward annual dividend yield 44.15%
Trailing annual dividend rate 3180.00
Trailing annual dividend yield 31,132.79%
5-year average dividend yield 44.65
Payout ratio 447.15%
Dividend date 314 Dec 2009
Ex-dividend date 428 Sept 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 30 Mar 2023
Most-recent quarter (mrq)30 Mar 2023


Profit margin 7.87%
Operating margin (ttm)13.88%

Management effectiveness

Return on assets (ttm)2.58%
Return on equity (ttm)5.27%

Income statement

Revenue (ttm)4.03T
Revenue per share (ttm)1,297.67
Quarterly revenue growth (yoy)9.50%
Gross profit (ttm)N/A
Net income avi to common (ttm)317.02B
Diluted EPS (ttm)0.72
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)533.53B
Total cash per share (mrq)171.6
Total debt (mrq)4.92T
Total debt/equity (mrq)77.37
Current ratio (mrq)0.97
Book value per share (mrq)2,043.75

Cash flow statement

Operating cash flow (ttm)977.16B
Levered free cash flow (ttm)468.63B